UNIVERSAL CAR Trademark

Trademark Overview


On Wednesday, April 4, 2018, a trademark application was filed for UNIVERSAL CAR with the United States Patent and Trademark Office. The USPTO has given the UNIVERSAL CAR trademark a serial number of 87863142. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, September 21, 2019. This trademark is owned by Celularity, Inc.. The UNIVERSAL CAR trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; biological substances for medical use, namely, placental- derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; medical preparations that comprise placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen, for treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; and written instructional materials distributed in connection with the aforesaid goo...
universal car

General Information


Serial Number87863142
Word MarkUNIVERSAL CAR
Filing DateWednesday, April 4, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, September 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"CAR"
Goods and ServicesBiological preparations for medical purposes for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; biological substances for medical use, namely, placental- derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; medical preparations that comprise placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen, for treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; and written instructional materials distributed in connection with the aforesaid goods

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelularity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Monday, September 23, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, September 21, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 13, 2019FINAL REFUSAL E-MAILED
Wednesday, February 13, 2019FINAL REFUSAL WRITTEN
Wednesday, January 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 24, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 24, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 24, 2018NON-FINAL ACTION WRITTEN
Monday, July 23, 2018ASSIGNED TO EXAMINER
Thursday, April 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 7, 2018NEW APPLICATION ENTERED IN TRAM